Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Carnival prices EUR 1bn note offering as part of debt restructure

(Sharecast News) - Carnival announced on Wednesday that it has priced a €1bn offering of senior unsecured notes due 2031, carrying an annual interest rate of 4.125%. The FTSE 250 cruise operator said the proceeds would be used to repay borrowings under its senior secured term loan facilities as part of ongoing efforts to reduce debt and simplify its capital structure.

It said the funds would fully repay borrowings on the 2027 first-priority senior secured term loan facility and partially repay the 2028 facility.

It followed a $450m prepayment made on 27 June towards the 2027 facility.

Carnival said the transaction formed part of a broader strategy to deleverage, lower interest costs, simplify its capital structure, and manage its debt maturity profile.

The notes were scheduled to mature on 15 July 2031, and would pay interest annually starting on 15 July 2026.

They would be unsecured but fully and unconditionally guaranteed on an unsecured basis by Carnival Corporation and certain subsidiaries.

The offering, which was expected to close on 7 July subject to customary conditions, included investment-grade style covenants.

At 1044 BST, shares in Carnival were up 1.54% in London at 1,913.69p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.